SCHEMBL7086969

SCHEMBL7086969

Cn1nnnc1CCN(Cc1cccc(C(=N)N)c1)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 8/20 0.39
▸ F2 P00734 4/20 0.39
▸ F7 P08709 4/20 0.39
▸ PRSS1 P07477 2/20 0.39
▸ PRSS2 P07478 2/20 0.39
▸ PRSS3 P35030 2/20 0.39
▸ GRIN2D O15399 2/20 0.38
▸ GRIN3B O60391 2/20 0.38
▸ GRIN1 Q05586 2/20 0.38
▸ GRIN2A Q12879 2/20 0.38
▸ GRIN2B Q13224 2/20 0.38
▸ GRIN2C Q14957 2/20 0.38
▸ GRIN3A Q8TCU5 2/20 0.38
▸ DAGLA Q9Y4D2 2/20 0.38
▸ LOXL2 Q9Y4K0 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ PPARG P37231 1/20 0.38
▸ HDAC1 Q13547 2/20 0.37
▸ HDAC6 Q9UBN7 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7083226 0.78 GRIN2D (0.59) F10F2F7PRSS1PRSS2
SCHEMBL7089328 0.76 PRSS1 (0.61) F10F2F7PRSS1PRSS2
SCHEMBL7086962 0.76 PRSS1 (0.39) F10F2F7PRSS1PRSS2
SCHEMBL7083982 0.76 GRIN2D (0.61) F10F2F7PRSS1PRSS2
SCHEMBL7090549 0.75 GRIN2D (0.57) F10F2PRSS1PRSS2PRSS3
SCHEMBL7090135 0.74 GRIN2D (0.56) F10F2F7PRSS1PRSS2
SCHEMBL16783177 0.73 DAGLA (0.50) DAGLAMEN1KMT2AHDAC1HDAC6
SCHEMBL7089974 0.72 F10 (0.45) F10F2F7PRSS1PRSS2
SCHEMBL7089289 0.72 PRSS1 (0.49) F10F2PRSS1PRSS2PRSS3
SCHEMBL7084315 0.72 GRIN2D (0.60) F10F2F7PRSS1PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030199698-A1 Carbamic acid esters as inhibitors of factor xa MERCK PATENT GMBH (DE) 2003-10-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030199698-A1 Carbamic acid esters as inhibitors of factor xa F11, F12, F13A1 F10 5/4885F2 4/4885F7 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback